GW Pharmaceuticals

GW Pharmaceuticals

Verified
Cannabinoid prescription medicines developer

Launch date
Employees
Ownership
Market cap
-
Net debt
-
Firm valuation
$7.2b (Public information from Feb 2021)
Histon England (HQ)